A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

Germline testing can identify hereditary cancer, which leads to implications for family members, cascade testing for relatives, and starting surveillance and prevention measures: Genetic testing in ...

State data from 2018 through 2022 shows prostate cancer is the leading cancer diagnosis in Cuyahoga County, yet 77% of cases ...

Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing ...

The Lehigh Valley Auto Show showcases innovation, creativity, and automotive excellence, drawing car enthusiasts from across the region. This year, it will also put men's health in the spotlight with ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.

HRR mutations are commonly of germline origin, with several real world studies suggesting a 23-44% probability of an HRR alteration to be of germline origin: 1 The following summarizes recommendations ...

Prostate cancer screening saves many more lives than earlier studies suggested, research shows. The results from the longest-running European trial show one life saved for every six men diagnosed, a ...

Prostate cancer kills more than 12,000 men a year in the UK, slightly more than the number of women who die from breast ...

The analysis – reported at the European Association of Urology (EAU) annual congress in London, UK – shows that it is "no longer rational to reject prostate cancer screening on one hand while ...

Watchdog finds failings in prostate cancer treatment in North Wales going back almost a decade.